LabCorp completes acquisition of PAML
LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.
LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.
CPhI North America
Cambrex Corporation is installing a fourth reactor suite at its High Point, NC-based facility as it continues to grow with its customers in the market, says company VP at CPhI North America.
Teva Pharmaceuticals has confirmed it intends to sell or close its Gödöllő manufacturing plant by the end of 2018.
Nova DFL’s dental adrenaline product has been denied marketing authorisation after French regulators raised seven critical deficiencies at its facility in Brazil.
Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.